NCT00037518已完成4 期
An Assessment of the Calcimimetic Agent AMG 073 for the Treatment of Subjects With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism.
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Amgen
- 入组人数
- 46
- 主要终点
- Changes in serum calcium and PTH
研究概览
简要总结
This study will assess an investigational medication for patients with severe primary hyperparathyroidism or parathyroid cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients must have parathyroid carcinoma or severe primary hyperparathyroidism; * Abnormally elevated calcium levels above 12.5 mg/dL; * Not be pregnant or nursing; * Not have had any type of cancer other than parathyroid carcinoma within the last 5 years.
排除标准
- 未提供
结局指标
主要结局
Changes in serum calcium and PTH
次要结局
- Safety and tolerability of cinacalcet
研究者
相似试验
终止
4 期
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving HemodialysisSecondary HyperparathyroidismNCT00446329Papageorgiou General Hospital15
进行中（未招募）
1 期
se of calcimimetics in primary hyperparathyroidism to predict the outcome of parathyroid surgeryPrimary hyperparathyroidism (PHPT) is a common disease, characterized by a high-normal calcium concentration and an inappropriately increased parathyroid hormone (PTH) levelMedDRA version: 14.1Level: LLTClassification code 10036693Term: Primary hyperparathyroidismSystem Organ Class: 100000004860EUCTR2012-005374-57-SEDepartment of Breast and Endocrine Surgery, Karolinska University Hospital100
已完成
1 期
Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.Acute Myelogenous LeukemiaMultiple MyelomaLymphomaNCT00299780Massachusetts General Hospital12
招募中
3 期
A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on HemodialysisSecondary HyperparathyroidismChronic Kidney DiseaseNCT03633708Amgen56
已完成
4 期
A Study of Teriparatide in Japanese Osteoporosis PatientsOsteoporosisNCT01430104Eli Lilly and Company30